ABC Arbitrage’s Tourmaline Bio TRML Stock Holding History

ABC Arbitrage’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-139,800	Closed	-$6.69M	–	417
2025 Q3	$6.69M	Buy	+139,800	New	+$3.88M	0.66%	38

ABC Arbitrage's TRML Position: Q4 2025 in Review

ABC Arbitrage sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 139,800 shares — an estimated $6.69M sold.

ABC Arbitrage first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $6.69M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

ABC Arbitrage reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
ABC Arbitrage sold 139,800 Tourmaline Bio shares in Q4 2025, an estimated $6.69M.
ABC Arbitrage first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
ABC Arbitrage's Tourmaline Bio position peaked at $6.69M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on ABC Arbitrage's 13F filing for Q4 2025, filed 4 Feb 2026.